ABEO

EPS: 17.20 Rev: 9M Net Inc: -17M

Income Statement

Expenses

Assets

Assets (Current)

Assets (Non-Current)

Liabilities

Liabilities (Current)

Liabilities (Non-Current)

Cash Flow

Cash Flow Investing

ABEO vs Biotechnology (76 peers) - Healthcare

Operating Margin

-1608.8%

-1639.5pp vs peers

Net Margin

1280.2%

+1254.7pp vs peers

ROIC

-66.5%

-164.0pp vs peers

Related: REGN INCY VRTX NTLA SVRA ARDX ALLO IOVA CHRS CPRX